Skip to main content
SpringerLink
Log in

EMEA recommends restricting use of moxifloxacin, norfloxacin

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. EMEA.EMEA recommends restricted use of oral norfloxacin-containing medicines in urinary infections. Media Release: 24 Jul 2008. Available from: URL: http://www.emea.europa.eu

  2. EMEA.European Medicines Agency recommends restricting the use of oral moxifloxacin-containing medicines. Media Release: 24 Jul 2008. Available from: URL: http://www.emea.europa.eu

  3. EMEA.Questions and answers on the recommendation to restrict the use of oral formulations of moxifloxacin-containing medicines. Media Release: 24 Jul 2008. Available from: URL: http://www.emea.europa.eu

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

EMEA recommends restricting use of moxifloxacin, norfloxacin. React. Wkly. 1213, 2 (2008). https://doi.org/10.2165/00128415-200812130-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200812130-00003

Keywords

Search

Navigation